Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Sean Ainsworth | Director | 2025-08-25 | 86,956 | $1.15 | $100.00kBuy |
Cam Gallagher | Director | 2025-08-25 | 869,565 | $1.15 | $1,000.00kBuy |
Nirav S. Jhaveri | Chief Financial Officer | 2025-02-13 | 8,207 | $1.15 | $9.44kSell |
Ashwath Jayagopal | Chief Scientific Dev. Ofc. | 2025-02-13 | 5,193 | $1.15 | $5.97kSell |
Rabourn Amy Zaremba | SVP of Finance | 2025-02-04 | 8,190 | $1.14 | $9.34kSell |
Bernhard Hoffmann | SVP of Corp. Dev. | 2025-02-04 | 6,751 | $1.14 | $7.70kSell |
George Magrath | Chief Executive Officer | 2024-12-26 | 100,000 | $0.98 | $97.60kBuy |
Benjamin R. Yerxa | President | 2024-11-21 | 10,000 | $0.98 | $9.83kBuy |
George Magrath | Chief Executive Officer | 2024-11-18 | 9,706 | $1.02 | $9.94kBuy |
George Magrath | Chief Executive Officer | 2024-11-15 | 90,294 | $1.01 | $91.20kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Sungkee Chung | 273.42% | 163,800,000 | $201.47M | Insider |
Sung Sook Park | 117.18% | 70,200,000 | $86.35M | Insider |
Frank Ferraro | 43.40% | 26,000,000 | $31.98M | Insider |
Inok Ahn | 23.37% | 14,000,000 | $17.22M | Insider |
Chang Ho Ahn | 19.21% | 11,510,000 | $14.16M | Insider |
Foundation Fighting Blindness Retinal Degeneration Fund | 15.84% | 9,492,171 | $11.68M | Insider |
Rexgene Biotech Co Ltd | 9.19% | 5,505,956 | $6.77M | Insider |
Perceptive Advisors LLC | 7.22% | 4,325,000 | $5.32M | Institution |
Bios Capital Management LP | 6.15% | 3,683,429 | $4.53M | Institution |
Nantahala Capital Management LLC | 5.59% | 3,345,923 | $4.12M | Institution |